Figure 1.

Primary obstacles in pursuing cannabis and cannabinoid research. Federal regulations, drug source, and funding are significant barriers to conducting cannabis and cannabinoid research, which can lead to significant delays in study onset. As depicted by the double-headed arrows, these challenges are intertwined with one another, creating a situation where overcoming one obstacle requires success in surmounting the others. IRB = institutional review board; FDA = US Food and Drug Administration.